Cheryl Murphy

483 total citations
7 papers, 396 citations indexed

About

Cheryl Murphy is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cell Biology. According to data from OpenAlex, Cheryl Murphy has authored 7 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Cell Biology. Recurrent topics in Cheryl Murphy's work include Protein Kinase Regulation and GTPase Signaling (2 papers), Advanced Biosensing Techniques and Applications (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Cheryl Murphy is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (2 papers), Advanced Biosensing Techniques and Applications (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Cheryl Murphy collaborates with scholars based in United States and United Kingdom. Cheryl Murphy's co-authors include Avril V. Somlyo, Susan I. Ramos, Andrew P. Somlyo, Charles E. Myers, Amy B. Hall, Brinley F. Furey, Yong Gu, Darin Takemoto, Yuxin Wang and Mark Wood and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Cheryl Murphy

7 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl Murphy United States	5	324	152	93	47	30	7	396
Francesca Miccichè Italy	9	279 0.9×	147 1.0×	43 0.5×	112 2.4×	23 0.8×	9	360
Maria Teresa Vento Italy	8	274 0.8×	153 1.0×	87 0.9×	105 2.2×	15 0.5×	9	406
Anton Chestukhin Israel	9	244 0.8×	139 0.9×	92 1.0×	60 1.3×	7 0.2×	14	359
Romain M. Larive France	11	234 0.7×	88 0.6×	40 0.4×	51 1.1×	10 0.3×	18	324
Jasminka Omerović United Kingdom	10	410 1.3×	183 1.2×	116 1.2×	62 1.3×	8 0.3×	11	553
Alice Boulghourjian Australia	6	227 0.7×	142 0.9×	39 0.4×	154 3.3×	15 0.5×	6	362
Hong-Jen Lee Taiwan	8	468 1.4×	182 1.2×	69 0.7×	59 1.3×	7 0.2×	8	608
Mervi Eeva United States	9	298 0.9×	150 1.0×	48 0.5×	97 2.1×	13 0.4×	10	429
Manon Ros France	8	231 0.7×	107 0.7×	72 0.8×	89 1.9×	10 0.3×	13	371
Iveta Dobreva Canada	9	322 1.0×	96 0.6×	215 2.3×	57 1.2×	25 0.8×	9	528

Countries citing papers authored by Cheryl Murphy

Since Specialization

Citations

This map shows the geographic impact of Cheryl Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Murphy more than expected).

Fields of papers citing papers by Cheryl Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Murphy. The network helps show where Cheryl Murphy may publish in the future.

Co-authorship network of co-authors of Cheryl Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Murphy. A scholar is included among the top collaborators of Cheryl Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Murphy. Cheryl Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Murphy, Cheryl, et al.. (2021). Abstract 3164: Modeling the metastatic niche interactions between patient tumor and mesenchymal cells to identify drivers of chemotherapy drug resistance. Cancer Research. 81(13_Supplement). 3164–3164. 1 indexed citations

2.

Hall, Amy B., Yuxin Wang, Diane M. Boucher, et al.. (2014). Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. Oncotarget. 5(14). 5674–5685. 149 indexed citations

3.

Tedford, Nathan C., Amy B. Hall, James R. Graham, et al.. (2009). Quantitative analysis of cell signaling and drug action via mass spectrometry‐based systems level phosphoproteomics. PROTEOMICS. 9(6). 1469–1487. 29 indexed citations

4.

Murphy, Cheryl, et al.. (2008). Profiling Protein Tyrosine Phosphorylation: A Quantitative 45-Plex Peptide-Based Immunoassay. SLAS DISCOVERY. 13(7). 626–637. 4 indexed citations

5.

Graham, James R., et al.. (2008). Quantitative measurement of epidermal growth factor receptor–mitogen-activated protein kinase signal transduction using a nine-plex, peptide-based immunoassay. Analytical Biochemistry. 375(2). 255–264. 7 indexed citations

6.

Somlyo, Avril V., et al.. (2000). Rho-Kinase Inhibitor Retards Migration and in Vivo Dissemination of Human Prostate Cancer Cells. Biochemical and Biophysical Research Communications. 269(3). 652–659. 205 indexed citations

7.

Kellie, Stuart, et al.. (1993). The interaction of the tyrosine kinase pp60src with membrane and cytoskeletal components.. PubMed. 47. 267–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact